Aardvark Therapeutics, Inc. (AARD)
1.32
+0.15
(+12.82%)
USD |
NASDAQ |
Nov 09, 11:35
Aardvark Therapeutics Price : 1.32 for Nov. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 06, 2026 | 1.10 | 1.18 | 1.09 | 1.17 | 221841.0 |
| Nov 05, 2026 | 1.18 | 1.231 | 1.095 | 1.11 | 375889.0 |
| Nov 04, 2026 | 1.25 | 1.28 | 1.169 | 1.26 | 216498.0 |
| Nov 03, 2026 | 1.22 | 1.29 | 1.21 | 1.23 | 267926.0 |
| Nov 02, 2026 | 1.37 | 1.396 | 1.20 | 1.20 | 345525.0 |
| Oct 30, 2026 | 1.39 | 1.46 | 1.33 | 1.36 | 467601.0 |
| Oct 29, 2026 | 1.48 | 1.53 | 1.362 | 1.44 | 955892.0 |
| Oct 28, 2026 | 1.22 | 1.59 | 1.176 | 1.51 | 2.026M |
| Oct 27, 2026 | 1.09 | 1.39 | 1.09 | 1.30 | 4.283M |
| Oct 26, 2026 | 1.245 | 1.39 | 0.93 | 1.08 | 4.958M |
| Oct 23, 2026 | 2.99 | 3.00 | 1.39 | 1.39 | 16.35M |
| Oct 22, 2026 | 4.27 | 4.31 | 3.89 | 3.95 | 1.415M |
| Oct 21, 2026 | 3.95 | 4.54 | 3.95 | 4.41 | 218457.0 |
| Oct 20, 2026 | 3.80 | 4.051 | 3.78 | 3.90 | 66698.00 |
| Oct 19, 2026 | 3.75 | 4.05 | 3.64 | 3.74 | 135284.0 |
| Oct 16, 2026 | 4.19 | 4.19 | 3.73 | 3.78 | 97165.00 |
| Oct 15, 2026 | 3.86 | 3.977 | 3.77 | 3.86 | 68798.00 |
| Oct 14, 2026 | 3.93 | 4.35 | 3.83 | 3.88 | 126566.0 |
| Oct 13, 2026 | 4.44 | 4.63 | 4.03 | 4.04 | 218304.0 |
| Oct 12, 2026 | 4.81 | 4.877 | 4.40 | 4.45 | 99865.00 |
| Oct 09, 2026 | 4.61 | 4.82 | 4.60 | 4.76 | 140865.0 |
| Oct 08, 2026 | 4.77 | 5.09 | 4.57 | 4.71 | 315971.0 |
| Oct 07, 2026 | 4.95 | 5.33 | 4.69 | 4.96 | 212131.0 |
| Oct 06, 2026 | 5.28 | 5.45 | 4.66 | 5.04 | 251856.0 |
| Oct 05, 2026 | 5.03 | 5.37 | 5.03 | 5.22 | 62253.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 279.50 |
| Bristol Myers Squibb Co. | 62.10 |
| ANI Pharmaceuticals, Inc. | 67.71 |
| Corcept Therapeutics, Inc. | 75.88 |
| Veru, Inc. | 2.18 |
Price Related Metrics
| PEG Ratio | -0.0046 |
| Price to Book Value | 0.3862 |
| Earnings Yield | -242.8% |
| Market Cap | 28.89M |
| PEGY Ratio | -0.0046 |